Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures (1-2-KiWI)

November 2, 2017 updated by: Prof. Dr. Andreas Eisenschenk, University Medicine Greifswald

Metacarpal V fractures are injuries of the upper extremities. They occur frequently, primarily in young adults.These fractures are caused by falling on the fist, sports accidents and direct or indirect forces.

Surgical intervention is necessary for fractures with a strong palmar angulation of the metacarpal bone or rotational deformity of the small finger. Due to the absence of guideline recommendations decisions about therapy are made taking into account logistical aspects, available hardware, individual expertise and preferences. The objective of the study is to compare the advantages and disadvantages of single versus double Kirschner wires for intramedullary fixation of metacarpal V fractures in order to standardize national therapy procedures.

Primary hypothesis:

In the surgical therapy of the dislocated and/or rotational deformed metacarpal V neck fracture, osteosynthesis with a single Kirschner wire is not inferior to osteosynthesis with a double Kirschner wire with regard to the functional outcome after 6 month, as measured with the Disabilities of the Arm, Shoulder and Hands Score (DASH).

Study Overview

Study Type

Interventional

Enrollment (Actual)

292

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10967
        • Vivantes Hospital Am Urban
      • Berlin, Germany, 10365
        • Sana Clinical Centre Lichtenberg
      • Berlin, Germany, 12683
        • Trauma Hospital Berlin
      • Düsseldorf, Germany, 40225
        • University Medicine Düsseldorf
      • Gummersbach, Germany, 51643
        • District Hospital Gummersbach
      • Halle, Germany, 06112
        • BG Kliniken Bergmannstrost
      • Hamburg, Germany, 21033
        • Berufsgenossenschaftliches Unfallkrankenhaus Hamburg
      • Hamburg, Germany, 220246
        • University Medicine Hamburg-Eppendorf
      • Ludwigshafen, Germany, 67071
        • Berufsgenossenschaftliches Unfallkrankenhaus Ludwigshafen
      • Rostock, Germany, 18055
        • University Medicine Rostock
      • Solingen, Germany, 42663
        • Municipal Clinic Solingen
    • Mecklenburg-Vorpommern
      • Greifswald, Mecklenburg-Vorpommern, Germany, 17489
        • University Medicine Greifswald

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients ≥18 years with a metacarpal V neck fracture with a palmar angulation and/or shortening and /or rotational deformity as determined on radiological diagnosis
  • Trauma within 10 days before appearing in the study centre
  • No specific medical treatment before
  • Ability to fully understand the character and implications of the clinical trial
  • Written or oral (in case of an injury of the dominant hand, if so attested by witnesses)consent

Exclusion Criteria:

  • Indications for conservative therapy
  • Patient is not suitable for anaesthesia
  • Other physical conditions or characteristics which made surgical interventions inappropriate or to risky (e.g. open fractures, polytrauma, pregnancy, acute infections, pathological fractures)
  • Prior participation in this study (e.g. injury of the contralateral hand) or participation in other interventional studies with the same objective
  • Physical or mental diseases which makes the consequent participation in diagnostic, therapy and the follow-up-examinations unlikely
  • Lacking language skills

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Single Kirschner Wire
Antegrade intramedullary fixation of with a single Kirschner wire.
Active Comparator: Double Kirschner Wire
Antegrade intramedullary fixation with double Kirschner wire.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Differences in functional outcome of the therapy with single or double Kirschner wires measured with the DASH score
Time Frame: 6 months after randomisation
6 months after randomisation

Secondary Outcome Measures

Outcome Measure
Time Frame
Malposition or angulation in the frontal and sagittal planes of max. 5°
Time Frame: 6 months after randomisation
6 months after randomisation
Shortening of the metacarpus >2mm
Time Frame: 6 months after randomisation
6 months after randomisation
Palmar angulation >30°
Time Frame: 6 months after randomisation
6 months after randomisation
Non-union/Pseudarthrosis
Time Frame: 6 months after randomisation
6 months after randomisation
Limitation of fist closure
Time Frame: 6 months after randomisation
6 months after randomisation
Flexion or extension lag
Time Frame: 6 months after randomisation
6 months after randomisation
Pain intensity <10 points (VAS)
Time Frame: 6 months after randomisation
6 months after randomisation
Duration of surgical intervention
Time Frame: 6 months after randomisation
6 months after randomisation
Rate of re-interventions
Time Frame: 6 months after randomisation
6 months after randomisation
Rate of infections
Time Frame: 6 months after randomisation
6 months after randomisation
Rate of perforation/dislocation/break of the fracture fixation devices
Time Frame: 6 months after randomisation
6 months after randomisation
Duration of inability to work
Time Frame: 6 months after randomisation
6 months after randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Andreas Eisenschenk, Prof. Dr., University Medicine Greifswald

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

March 1, 2013

First Submitted That Met QC Criteria

March 1, 2013

First Posted (Estimate)

March 4, 2013

Study Record Updates

Last Update Posted (Actual)

November 6, 2017

Last Update Submitted That Met QC Criteria

November 2, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1-2-KiWI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fracture of Metacarpal Bone

Clinical Trials on Single Kirschner Wire

3
Subscribe